Gilead Sciences — 2022 Investments
1 investments dated 2022 · listed companies and verified rows first · show all
Curebasecurebase.aiin𝕏May 2022 · $40M
Curebase provides a software platform for clinical trial management, serving contract research coordinators and trial sites.
AI & Machine LearningBiotechDigital HealthHealthtechSaaSFort Lauderdale, US
Storm Stillman(Chief Executive Officer)inTom Lemberg(Founder)in
Co-investorsAcrew CapitalBold Capital PartnersBreyer CapitalFuture Planet CapitalNotable CapitalXfund+6 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.